AbbVie (ABBV) EBITDA (2012 - 2026)
AbbVie (ABBV) reported EBITDA of $4.0 billion for Q1 2026, up 6.88% year-over-year from $3.7 billion in Q1 2025, and down 12.19% on a QoQ basis from $4.5 billion in Q4 2025.
AbbVie (ABBV) has 15 years of EBITDA data on file, last reported at $4.0 billion in Q1 2026.
- Quarterly EBITDA rose 6.88% year-over-year to $4.0 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.3 billion (up 52.22% YoY) and the FY2025 annual result came in at $15.1 billion, up 64.99% from the prior year.
- EBITDA declined to $4.0 billion in Q1 2026 per ABBV's latest filing, from $4.5 billion in the prior quarter.
- Across five years, EBITDA topped out at $5.5 billion in Q4 2022 and bottomed at -$1.5 billion in Q4 2024.
- The 5-year median for EBITDA is $3.8 billion (2024), against an average of $3.5 billion.
- The widest annual swing landed in 2024, when EBITDA tumbled 146.64%; it then jumped 404.97% in 2025.
- Tracing ABBV's EBITDA over 5 years: stood at $5.5 billion in 2022, then tumbled by 41.93% to $3.2 billion in 2023, then plunged by 146.64% to -$1.5 billion in 2024, then jumped by 404.97% to $4.5 billion in 2025, then dropped by 12.19% to $4.0 billion in 2026.
- Per Business Quant, the three latest ABBV EBITDA figures stand at $4.0 billion (Q1 2026), $4.5 billion (Q4 2025), and $1.9 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 9.50 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 6.36 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 3.99 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | -7.73 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 2.67 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 2.59 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | -6.71 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 2.83 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.99 Bn |
| Dec 31, 2025 | 4.54 Bn |
| Sep 30, 2025 | 1.90 Bn |
| Jun 30, 2025 | 4.89 Bn |
| Mar 31, 2025 | 3.73 Bn |
| Dec 31, 2024 | -1.49 Bn |
| Sep 30, 2024 | 3.83 Bn |
| Jun 30, 2024 | 4.00 Bn |
| Mar 31, 2024 | 2.80 Bn |
| Dec 31, 2023 | 3.20 Bn |
| Sep 30, 2023 | 2.28 Bn |
| Jun 30, 2023 | 4.51 Bn |
| Mar 31, 2023 | 2.77 Bn |
| Dec 31, 2022 | 5.50 Bn |
| Sep 30, 2022 | 4.60 Bn |
| Jun 30, 2022 | 3.30 Bn |
| Mar 31, 2022 | 4.72 Bn |
| Dec 31, 2021 | 5.07 Bn |
| Sep 30, 2021 | 4.31 Bn |
| Jun 30, 2021 | 4.44 Bn |
| Mar 31, 2021 | 4.10 Bn |
| Dec 31, 2020 | 3.75 Bn |
| Sep 30, 2020 | 3.26 Bn |
| Jun 30, 2020 | 752.00 Mn |
| Mar 31, 2020 | 3.60 Bn |
| Dec 31, 2019 | 3.96 Bn |
| Sep 30, 2019 | 2.62 Bn |
| Jun 30, 2019 | 3.40 Bn |
| Mar 31, 2019 | 3.01 Bn |
| Dec 31, 2018 | -2.44 Bn |
| Sep 30, 2018 | 3.16 Bn |
| Jun 30, 2018 | 2.76 Bn |
| Mar 31, 2018 | 2.90 Bn |
| Dec 31, 2017 | 1.78 Bn |
| Sep 30, 2017 | 2.69 Bn |
| Jun 30, 2017 | 2.66 Bn |
| Mar 31, 2017 | 2.41 Bn |
| Dec 31, 2016 | 2.31 Bn |
| Sep 30, 2016 | 2.36 Bn |
| Jun 30, 2016 | -90.00 Mn |
| Mar 31, 2016 | 2.28 Bn |
| Dec 31, 2015 | 2.11 Bn |
| Sep 30, 2015 | 1.89 Bn |
| Jun 30, 2015 | 337.00 Mn |
| Mar 31, 2015 | 1.69 Bn |
| Dec 31, 2014 | -415.00 Mn |
| Sep 30, 2014 | 960.00 Mn |
| Jun 30, 2014 | 1.52 Bn |
| Mar 31, 2014 | 1.35 Bn |
| Dec 31, 2013 | 1.54 Bn |
| Sep 30, 2013 | 1.37 Bn |
| Jun 30, 2013 | 1.45 Bn |
| Mar 31, 2013 | 1.31 Bn |
| Dec 31, 2012 | 1.82 Bn |
| Sep 30, 2012 | 1.60 Bn |
| Jun 30, 2012 | 1.42 Bn |
| Mar 31, 2012 | 978.00 Mn |